United Therapeutics (UTHR) CEO trades shares under Rule 10b5-1 plan

Q: What did UTHR CEO Martine Rothblatt report in this Form 4 filing?

The filing shows CEO Martine Rothblatt exercised stock options for 19,000 shares at $146.03 and sold 19,075 shares in open-market trades at prices mainly in the high $570s to low $580s , while retaining a sizable share position.

Q: How many UNITED THERAPEUTICS (UTHR) shares does the CEO hold after these trades?

After the reported transactions, the CEO directly holds 40,513 common shares . The filing also lists additional indirect holdings through family trusts and her spouse, with individual indirect positions such as 258,117 and 45,596 shares as of March 13, 2026.

Q: How many UTHR stock options did the CEO exercise in this Form 4 period?

The CEO exercised stock options covering 19,000 shares of UNITED THERAPEUTICS common stock at an exercise price of $146.03 per share. These options relate to grants expiring on March 15, 2027 , as indicated by the derivative transaction details in the filing.

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

UNITED THERAPEUTICS Corp Chairperson & CEO Martine A. Rothblatt reported a planned combination of option exercises and share sales. She exercised stock options for 19,000 shares of common stock at an exercise price of $146.03 per share, then sold 19,075 shares in multiple open-market trades at prices mostly around the high-$570s to low-$580s.

After these direct transactions, she holds 40,513 common shares directly. In addition, indirect holdings include shares held by family trusts and her spouse, with trust and spouse positions ranging from 10,962 to 258,117 shares as of March 13, 2026. The filing notes that the option exercises and resulting sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025.

Insider Trade Summary 10b5-1

Net Seller: 19,075 shares ($11,057,621)

Net Sell 26 txns

Insider ROTHBLATT MARTINE A

Role Chairperson & CEO

Sold 19,075 shs ($11.06M)

Type	Security	Shares	Price	Value
Exercise	Stock Option	9,500	$0.00	--
Exercise	Common Stock	9,500	$146.03	$1.39M
Sale	Common Stock	80	$575.29	$46K
Sale	Common Stock	880	$576.9787	$508K
Sale	Common Stock	629	$577.8085	$363K
Sale	Common Stock	684	$579.1401	$396K
Sale	Common Stock	2,255	$580.0158	$1.31M
Sale	Common Stock	2,819	$581.0508	$1.64M
Sale	Common Stock	1,624	$582.0508	$945K
Sale	Common Stock	202	$583.4065	$118K
Sale	Common Stock	327	$584.2398	$191K
Exercise	Stock Option	9,500	$0.00	--
Exercise	Common Stock	9,500	$146.03	$1.39M
Sale	Common Stock	280	$574.2495	$161K
Sale	Common Stock	404	$575.25	$232K
Sale	Common Stock	80	$575.895	$46K
Sale	Common Stock	1,360	$577.6214	$786K
Sale	Common Stock	1,164	$578.4129	$673K
Sale	Common Stock	1,580	$579.6483	$916K
Sale	Common Stock	3,675	$580.5458	$2.13M
Sale	Common Stock	957	$581.5036	$556K
Sale	Common Stock	75	$536.95	$40K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option — 36,000 shares (Direct); Common Stock — 50,013 shares (Direct); Common Stock — 324,443 shares (Indirect, by Trust)

Footnotes (1)

This transaction was not reported earlier due to administrative error. This transaction was executed in multiple trades at prices ranging from $580.10 to $581.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $581.12 to $581.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $576.47 to $577.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $577.56 to $578.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $578.57 to $579.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $579.57 to $580.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $580.57 to $581.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $581.57 to $582.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $582.66 to $583.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $584.09 to $584.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026. This transaction was executed in multiple trades at prices ranging from $573.75 to $574.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $574.75 to $575.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $575.88 to $575.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $577.00 to $577.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $578.04 to $579.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $579.09 to $580.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Options exercised: 19,000 shares Exercise price: $146.03 per share Shares sold: 19,075 shares +4 more

7 metrics

Options exercised 19,000 shares Stock options for common stock exercised at $146.03 per share

Exercise price $146.03 per share Exercise price of stock options converting into common stock

Shares sold 19,075 shares Total common shares sold in open-market trades

Post-trade direct holding 40,513 shares Common stock held directly after reported transactions

Largest indirect trust holding 258,117 shares Common stock held indirectly by a family trust as of March 13, 2026

10b5-1 plan option pool 1,734,410 stock options Options referenced in Rule 10b5-1 plan expiring March 17, 2027

Representative sale price $580.55 per share One weighted average sale price for open-market transactions

Key Terms

Rule 10b5-1 trading plan, weighted average price, family trusts, stock options, +1 more

5 terms

Rule 10b5-1 trading plan financial

"exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported above reflects the weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

family trusts financial

"Shares held in family trusts as to which the Reporting Person shares investment power"

stock options financial

"This exercise of stock options and sale of the resulting shares of common stock"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

open-market sale financial

"transaction_code_description": "Sale in open market or private transaction""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 Insider Transactions: What Each Field Means →

04/16/2026 - 04:31 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROTHBLATT MARTINE A

(Last)

(First)

(Middle)

C/O UNITED THERAPEUTICS CORPORATION

1000 SPRING STREET

(Street)

SILVER SPRING

MARYLAND

20910

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chairperson & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/13/2026⁽¹⁾		S		75	D	$536.95	324,443	I	by Trust⁽²⁾
Common Stock	04/14/2026		M⁽³⁾		9,500	A	$146.03	50,013	D
Common Stock	04/14/2026		S⁽³⁾		280	D	$574.2495⁽⁴⁾	49,733	D
Common Stock	04/14/2026		S⁽³⁾		404	D	$575.25⁽⁵⁾	49,329	D
Common Stock	04/14/2026		S⁽³⁾		80	D	$575.895⁽⁶⁾	49,249	D
Common Stock	04/14/2026		S⁽³⁾		1,360	D	$577.6214⁽⁷⁾	47,889	D
Common Stock	04/14/2026		S⁽³⁾		1,164	D	$578.4129⁽⁸⁾	46,725	D
Common Stock	04/14/2026		S⁽³⁾		1,580	D	$579.6483⁽⁹⁾	45,145	D
Common Stock	04/14/2026		S⁽³⁾		3,675	D	$580.5458⁽¹⁰⁾	41,470	D
Common Stock	04/14/2026		S⁽³⁾		957	D	$581.5036⁽¹¹⁾	40,513	D
Common Stock	04/15/2026		M⁽³⁾		9,500	A	$146.03	50,013	D
Common Stock	04/15/2026		S⁽³⁾		80	D	$575.29	49,933	D
Common Stock	04/15/2026		S⁽³⁾		880	D	$576.9787⁽¹²⁾	49,053	D
Common Stock	04/15/2026		S⁽³⁾		629	D	$577.8085⁽¹³⁾	48,424	D
Common Stock	04/15/2026		S⁽³⁾		684	D	$579.1401⁽¹⁴⁾	47,740	D
Common Stock	04/15/2026		S⁽³⁾		2,255	D	$580.0158⁽¹⁵⁾	45,485	D
Common Stock	04/15/2026		S⁽³⁾		2,819	D	$581.0508⁽¹⁶⁾	42,666	D
Common Stock	04/15/2026		S⁽³⁾		1,624	D	$582.0508⁽¹⁷⁾	41,042	D
Common Stock	04/15/2026		S⁽³⁾		202	D	$583.4065⁽¹⁸⁾	40,840	D
Common Stock	04/15/2026		S⁽³⁾		327	D	$584.2398⁽¹⁹⁾	40,513	D
Common Stock								166	I	by Spouse
Common Stock								258,117	I	by Trust⁽²⁰⁾
Common Stock								45,596	I	by Trust⁽²¹⁾
Common Stock								10,962	I	by Trust⁽²²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$146.03	04/14/2026		M⁽³⁾			9,500	03/15/2020	03/15/2027	Common Stock	9,500	$0.00	45,500	D
Stock Option	$146.03	04/15/2026		M⁽³⁾			9,500	03/15/2020	03/15/2027	Common Stock	9,500	$0.00	36,000	D

Explanation of Responses:

1. This transaction was not reported earlier due to administrative error.

2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

3. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

4. This transaction was executed in multiple trades at prices ranging from $573.75 to $574.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. This transaction was executed in multiple trades at prices ranging from $574.75 to $575.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

6. This transaction was executed in multiple trades at prices ranging from $575.88 to $575.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

7. This transaction was executed in multiple trades at prices ranging from $577.00 to $577.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

8. This transaction was executed in multiple trades at prices ranging from $578.04 to $579.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

9. This transaction was executed in multiple trades at prices ranging from $579.09 to $580.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

10. This transaction was executed in multiple trades at prices ranging from $580.10 to $581.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

11. This transaction was executed in multiple trades at prices ranging from $581.12 to $581.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

12. This transaction was executed in multiple trades at prices ranging from $576.47 to $577.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

13. This transaction was executed in multiple trades at prices ranging from $577.56 to $578.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

14. This transaction was executed in multiple trades at prices ranging from $578.57 to $579.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

15. This transaction was executed in multiple trades at prices ranging from $579.57 to $580.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

16. This transaction was executed in multiple trades at prices ranging from $580.57 to $581.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

17. This transaction was executed in multiple trades at prices ranging from $581.57 to $582.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

18. This transaction was executed in multiple trades at prices ranging from $582.66 to $583.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

19. This transaction was executed in multiple trades at prices ranging from $584.09 to $584.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

20. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

21. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

22. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

Remarks:

	/s/ John S. Hess, Jr. under Power of Attorney	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did UTHR CEO Martine Rothblatt report in this Form 4 filing?

The filing shows CEO Martine Rothblatt exercised stock options for 19,000 shares at $146.03 and sold 19,075 shares in open-market trades at prices mainly in the high $570s to low $580s, while retaining a sizable share position.

How many UNITED THERAPEUTICS (UTHR) shares does the CEO hold after these trades?

After the reported transactions, the CEO directly holds 40,513 common shares. The filing also lists additional indirect holdings through family trusts and her spouse, with individual indirect positions such as 258,117 and 45,596 shares as of March 13, 2026.

Were the UTHR insider transactions made under a Rule 10b5-1 plan?

Yes. A footnote states the option exercises and resulting common stock sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025, which is scheduled to run until certain option exercises are completed or until December 31, 2026.

What prices were UTHR shares sold for in the CEO’s recent transactions?

The CEO’s sales occurred in multiple trades at weighted average prices mostly between about $573.75 and $584.24 per share. Several footnotes explain that each reported price reflects a weighted average over numerous individual trades within specified price ranges.

How many UTHR stock options did the CEO exercise in this Form 4 period?

The CEO exercised stock options covering 19,000 shares of UNITED THERAPEUTICS common stock at an exercise price of $146.03 per share. These options relate to grants expiring on March 15, 2027, as indicated by the derivative transaction details in the filing.

What ongoing option exercise plan is described for UNITED THERAPEUTICS’ CEO?

A footnote explains that the CEO’s 10b5-1 plan will continue until either 1,734,410 stock options expiring on March 17, 2027 are exercised or until December 31, 2026, whichever occurs first, outlining a structured schedule for further potential exercises and sales.